{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T15:53:52Z","timestamp":1694015632096},"reference-count":34,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,6,15]]},"DOI":"10.2169\/internalmedicine.6399-20","type":"journal-article","created":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T22:06:03Z","timestamp":1612130763000},"page":"1963-1969","source":"Crossref","is-referenced-by-count":2,"title":["The First Case of Eosinophilic Granulomatosis with Polyangiitis Simultaneously Demonstrating Various Clinical Manifestations with Retroperitoneal Fibrosis and Membranous Nephropathy"],"prefix":"10.2169","volume":"60","author":[{"given":"Isao","family":"Kondo","sequence":"first","affiliation":[{"name":"Department of Nephrology, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Nephrology, National Center for Global Health and Medicine, Japan"},{"name":"Department of Nephrology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Nephrology, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Katagiri","sequence":"additional","affiliation":[{"name":"Department of Nephrology, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Hinoshita","sequence":"additional","affiliation":[{"name":"Department of Nephrology, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Greco A, Rizzo MI, De Virgilio A, et al. Churg-Strauss syndrome. Autoimmun Rev 14: 341-348, 2015.","DOI":"10.1016\/j.autrev.2014.12.004"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Groh M, Pagnoux C, Baldini C, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med 26: 545-553, 2015.","DOI":"10.1016\/j.ejim.2015.04.022"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Prete M, Indiveri F, Perosa F. Vasculitides: proposal for an integrated nomenclature. Autoimmun Rev 15: 167-173, 2016.","DOI":"10.1016\/j.autrev.2015.10.008"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 63: 65-81, 1984.","DOI":"10.1097\/00005792-198403000-00001"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33: 1094-1100, 1990.","DOI":"10.1002\/art.1780330806"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mukhtyar C, Lee R, Brown D, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68: 1827-1832, 2009.","DOI":"10.1136\/ard.2008.101279"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Naito M, Takei T, Eguchi A, Uchida K, Tsuchiya K, Nitta K. Monitoring of blood cyclosporine concentration in steroid-resistant nephrotic syndrome. Intern Med 47: 1567-1572, 2008.","DOI":"10.2169\/internalmedicine.47.1088"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sinico RA, Bottero P. Churg-Strauss angiitis. Best Pract Res Clin Rheumatol 23: 355-366, 2009.","DOI":"10.1016\/j.berh.2009.02.004"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gioffredi A, Maritati F, Oliva E, Buzio C. Eosinophilic granulomatosis with polyangiitis: an overview. Front Immunol 5: 549, 2014.","DOI":"10.3389\/fimmu.2014.00549"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Groh M, Pagnoux C, Baldini C, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med 26: 545-553, 2015.","DOI":"10.1016\/j.ejim.2015.04.022"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ormond JK. Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process. J Urol 59: 1072-1079, 1948.","DOI":"10.1016\/S0022-5347(17)69482-5"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Uibu T, Oksa P, Auvinen A, et al. Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet 363: 1422-1426, 2004.","DOI":"10.1016\/S0140-6736(04)16100-X"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Vaglio A, Manenti L, Allegri L, Ferrozzi F, Corradi D, Buzio C. ANCA-positive periaortic vasculitis: does it fall within the spectrum of vasculitis? J Intern Med 251: 268-271, 2002.","DOI":"10.1046\/j.1365-2796.2002.00948.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gonz\u00e1lez Revilla EM, Fernandez AA, Ramirez MTR, Pardo SC, Moragues MAJ. Retroperitoneal fibrosis with periaortitis: a case report of an unusual form of presentation of granulomatosis with polyangiitis. Respir Med Case Rep 19: 121-124, 2016.","DOI":"10.1016\/j.rmcr.2016.08.009"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Fujii K, Hidaka Y. Churg-Strauss syndrome complicated by chronic periaortitis: a case report and review of the literature. Intern Med 51: 109-112, 2012.","DOI":"10.2169\/internalmedicine.51.5985"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hervier B, Masseau A, Bossard C, Agard C, Hamidou M. Vasavasoritis of the aorta and fatal myocarditis in fulminant Churg-Strauss syndrome. Rheumatology 47: 1729-1730, 2008.","DOI":"10.1093\/rheumatology\/ken329"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. van Bommel EF, Siemes C, Hak LE, van der Veer SJ, Hendriksz TR. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis 49: 615-625, 2007.","DOI":"10.1053\/j.ajkd.2007.02.268"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Fervenza FC, Sethi S, Specks U. Idiopathic membranous nephropathy: diagnosis and treatment. Clin J Am Soc Nephrol 3: 905-919, 2008.","DOI":"10.2215\/CJN.04321007"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ronco P, Debiec H. Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization. J Am Soc Nephrol 16: 1205-1213, 2005.","DOI":"10.1681\/ASN.2004121080"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sinico RA, Di Toma L, Maggiore U, et al. Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis 47: 770-779, 2006.","DOI":"10.1053\/j.ajkd.2006.01.026"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Mahmood SB, Ahmad H, Wu J, Haselby D, LeClaire MM, Nasr R. Anti-neutrophil cytoplasmic antibody-positive eosinophilic granulomatosis with polyangiitis: can it cause membranous nephropathy? Scand J Rheumatol 48: 256-257, 2019.","DOI":"10.1080\/03009742.2019.1580765"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Zhu Y, Chang Q, Cao X, et al. Co-occurrence of PLA2R-positive membranous nephropathy without crescents, and PR3-positive eosinophilic granulomatosis with polyangiitis. Clin Nephrol 92: 208-215, 2019.","DOI":"10.5414\/CN109662"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Shirota S, Tsuchiya K, Takada M, et al. Retroperitoneal fibrosis associated with membranous nephropathy effectively treated with steroids. Intern Med 41: 20-25, 2002.","DOI":"10.2169\/internalmedicine.41.20"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Cattran DC, Brenchley PE. Membranous nephropathy: integrating basic science into improved clinical management. Kidney Int 91: 566-574, 2017.","DOI":"10.1016\/j.kint.2016.09.048"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Wang X, Song X, Liu Y, Zhang W, An W, Tu Y. Treatment of membranous nephropathy with mizoribine: a control trial. Life Sci 154: 75-78, 2016.","DOI":"10.1016\/j.lfs.2016.04.012"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hashimoto Y, Ogata H, Yamasaki R, et al. Chronic inflammatory demyelinating polyneuropathy with concurrent membranous nephropathy: an anti-paranode and podocyte protein antibody study and literature survey. Front Neurol 9: 997, 2018.","DOI":"10.3389\/fneur.2018.00997"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Nazarali S, Mathey EK, Tang D, Margetts PJ, Baker SK. Chronic inflammatory demyelinating polyneuropathy and concurrent membranous nephropathy. Can J Neurol Sci 47: 585-587, 2020.","DOI":"10.1017\/cjn.2020.46"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Lian L, Wang C, Tian JL. IgG4-related retroperitoneal fibrosis: a newly characterized disease. Int J Rheum Dis 19: 1049-1055, 2016.","DOI":"10.1111\/1756-185X.12863"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Torre ED, Mattoo H, Mahajan VS, Carruthers M, Pillai S, Stone JH. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy 69: 269-272, 2014.","DOI":"10.1111\/all.12320"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Alexander MP, Larsen CP, Gibson IW, et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int 83: 455-462, 2013.","DOI":"10.1038\/ki.2012.382"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Stone JH. IgG4: a tantalizing link between causes of membranous glomerulonephritis and systemic disease. Kidney Int 83: 348-350, 2013.","DOI":"10.1038\/ki.2012.454"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Baptista B, Casian A, Gunawardena H, D'Cruz D, Rice CM. Neurological manifestations of IgG4-related disease. Curr Treat Options Neurol 19: 14, 2017.","DOI":"10.1007\/s11940-017-0450-9"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wallace ZS, Zhang Y, Perugino CA, Naden R, Choi HK, Stone JH. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis 78: 406-412, 2019.","DOI":"10.1136\/annrheumdis-2018-214603"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Wallace ZS, Deshpande V, Mattoo H, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol 67: 2466-2475, 2015.","DOI":"10.1002\/art.39205"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/12\/60_6399-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T03:32:56Z","timestamp":1624073576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/12\/60_6399-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6399-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]}}}